Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Famciclovir PK and Safety in Adolescents with Recurrent Herpes Labialis
NCT00878072Phase 3Completed
- Sponsor
- Novartis
- Start
- Mar 2009
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of famciclovir in herpes labialis, sponsored by Novartis. Primary endpoints: Number of Participants Reported Adverse Events (AEs) and Serious Adverse Events (SAEs) and Number of Participants With Clinically Significant Laboratory Abnormalities. Started Mar 2009; status: completed.
02
Drugs
famciclovir
03
Conditions
herpes labialis
Beyond the preview
Go deeper on NCT00878072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00878072.